Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oyster Point Pharma Inc (OYST)

Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oyster Point Pharma Inc 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 USA

www.oysterpointrx.com P: 609-382-9032

Description:

Oyster Point Pharma Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ocular surface diseases. The company's lead product candidate, OC-01, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Oyster Point Pharma Inc. is based in Princeton, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 299,847
Enterprise Value, $K 196,237
Shares Outstanding, K 26,844
Annual Sales, $ 24,540 K
Annual Net Income, $ -100,660 K
Last Quarter Sales, $ 5,590 K
Last Quarter Net Income, $ -36,750 K
60-Month Beta 1.35
% of Insider Shareholders 17.90%
% of Institutional Shareholders 96.70%
Float, K 22,039
% Float 82.10%
Short Volume Ratio 0.52

Growth:

1-Year Return -41.09%
3-Year Return -56.81%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.37 on 11/10/22
Next Earnings Date 02/23/23
Earnings Per Share ttm -6.65
EPS Growth vs. Prev Qtr 26.74%
EPS Growth vs. Prev Year -101.47%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OYST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -490.33%
Return-on-Assets % -108.29%
Profit Margin % -410.19%
Debt/Equity -4.15
Price/Sales 12.20
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.83
Interest Coverage -25.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar